United Services Automobile Association Invests $277,000 in Prestige Consumer Healthcare Inc. $PBH

United Services Automobile Association acquired a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 3,257 shares of the company’s stock, valued at approximately $277,000.

Other large investors also recently modified their holdings of the company. Opal Wealth Advisors LLC bought a new position in shares of Prestige Consumer Healthcare in the 1st quarter worth $38,000. McIlrath & Eck LLC lifted its holdings in shares of Prestige Consumer Healthcare by 19.1% in the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock worth $75,000 after purchasing an additional 154 shares in the last quarter. Costello Asset Management INC bought a new position in shares of Prestige Consumer Healthcare in the 1st quarter worth $112,000. GAMMA Investing LLC lifted its holdings in shares of Prestige Consumer Healthcare by 35.9% in the 1st quarter. GAMMA Investing LLC now owns 1,879 shares of the company’s stock worth $162,000 after purchasing an additional 496 shares in the last quarter. Finally, KBC Group NV lifted its holdings in shares of Prestige Consumer Healthcare by 7.4% in the 1st quarter. KBC Group NV now owns 2,199 shares of the company’s stock worth $189,000 after purchasing an additional 151 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PBH. Wall Street Zen cut Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Zacks Research cut Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a report on Thursday, September 4th. Finally, Canaccord Genuity Group cut their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $93.33.

Prestige Consumer Healthcare Price Performance

PBH opened at $63.31 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The company has a market capitalization of $3.12 billion, a price-to-earnings ratio of 14.86, a P/E/G ratio of 2.06 and a beta of 0.46. The firm’s fifty day moving average price is $70.53 and its two-hundred day moving average price is $79.23. Prestige Consumer Healthcare Inc. has a 1 year low of $62.95 and a 1 year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). The firm had revenue of $249.53 million for the quarter, compared to analysts’ expectations of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.Prestige Consumer Healthcare’s revenue was down 6.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.